Cytochrome c induces caspase-dependent apoptosis in intact hematopoietic cells and overrides apoptosis suppression mediated by bcl-2, growth factor signaling, MAP-kinase-kinase, and malignant change

Blood

Volumn 92, Issue 4, 1998, Pages 1235-1246

  Garland, John M ^a,c   Rudin, Claudius ^b  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; DNA FRAGMENT; GROWTH FACTOR; INTERLEUKIN 3; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL METABOLISM; CELL SURVIVAL; ELECTROPORATION; FLOW CYTOMETRY; HEMATOPOIETIC CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0032529676     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1235     Document Type: Article

References (62)

1. Nagata S: Apoptosis by death factor (review). Cell 88:355, 1997
2. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME: FLICE is activated by association with the CD95 death-inducing signalling complex (DISC). EMBO J 16:2794, 1996
3. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in FAS/ APO-1- and TNF receptor-induced cell death. Cell 85:803, 1996
4. Enari M, Talanian RV, Wong WW, Nagata S: Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723, 1996
5. Whyte M: ICE/CED-3 proteases in apoptosis (review). Trends Cell Biol 6:245, 1996
6. Tewari M, Quan LT: Yama/CPP32b, a mammalian homologue of CED 3 is a Crem-A-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801, 1995
7. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Gueskens M, Kroemer G: Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184:1331, 1996
8. Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147, 1996
9. Reed JC: Cytochrome c: Can't live with it - can't live without it. Cell 91:559, 1997
10. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129, 1997
11. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cytbchrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275:1132, 1997
12. Zou H, Henzel WJ, Liu X, Lutsschig A, Wang X: Apaf-1, a human protein homologous to C. elegans CED-4 participates in cytochrome c-dependent activation of caspase 3. Cell 90:405, 1997
13. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S: A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 391:43, 1998
14. Kluck R, Martin SJ, Hoffman BM, Zhou JS, Green DR, Newmeyer DD: Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J 16:4639, 1997
15. Hockenbery D, Nunez G, Milliman C, Schrieber RD, Korsmeyer S: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
16. Vaux D, Corey S, Adams JM: Bcl-2 gene promotes haematopoietic cell survival and co-operates with c-myc to immortalise pre-B cells. Nature 335:440, 1988
17. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman C, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241, 1993
18. Collins MK, Marvel J, Malde P, Lopez-Rivas A: Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med 176:1043, 1992
19. Garland JM, Halestrap A: Energy metabolism during apoptosis: bcl-2 promotes survival in haematopoietic cells induced to apoptose by growth factor withdrawal by stabilising a form of metabolic arrest. J Biol Chem 272:4680, 1997
20. Garland JM, Sondergaard KS, Jolly J: Redox regulation of apoptosis in inlerleukin-3 dependent haematopoietic cells; absence of alteration both mitochondrial membrane potential and free radical production during apoptosis induced by IL3 withdrawal. Br J Haematol 99:756, 1997
21. Garland JM, Robin P, Harel-Bellan A: Haematopoietic stem cell lines activate novel enhancer-dependent expression of reporter DNA immediately after transfection by mechanisms involving Interleukin 3 and protein kinase c. Leukaemia 6:729, 1992
22. Marvel J, Perkins GR, Rivas AL, Collins M: Growth factor starvation of bcl-2 over-expressing murine bone marrow cells induced refractoriness to IL3 stimulation of proliferation. Oncogene 9:1117, 1994
23. Perkins GR, Marshall CJ, Collins MK: The role of MAP kinase kinase in Interleukin-3 stimulation of proliferation. Blood 87:3669, 1996
24. Dexter TM, Garland JM, Scott D, Skolnik E, Metcalf D: Growth of factor-dependent haematopoietic cell lines. J Exp Med 149:1036, 1980
25. Fisher WR, Taniuchi H, Anfinsen CB: On the role of heme in the formation of the structure of cytochrome c. J Biol Chem 248:3188, 1973
26. Garland JM: Involvement of interleukin 3 in lymphocyte biology and leukaemogenesis. Lymphokines 9:153, 1984
27. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassata P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795, 1992
28. Reers M, Smith TW, Bo Chen L: J-aggregate formation of a carbocyanine as quantitative fluorescent indicator of membrane potential. Biochemistry 30:4480, 1991
29. Faliero L, Kobayashi R, Fearnhead H, Lazebnik Y: Multiple species of CPP32 and Mch2 are the major caspases present in apoptotic cells. EMBO J 16:271, 1997
30. Jia L, Kelsey SM, Grahn MF, Jiang X-R, Newland AC: Increased activity and sensitivity of mitochondrial respiratory enzymes to tumor necrosis factor α-mediated inhibition is associated with increased cytotoxicity in drug-resistant leukaemic cell lines. Blood 87:2401, 1996
31. L can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Natl Acad Sci USA 94:3759, 1997
32. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED 3 protease nomenclature. Cell 87:171, 1996
33. Li FL, Srinivasan A, Wang Y, Armstrong RC, Tomaselli KJ, Fritz LC: Cell-specific induction of apoptosis by microinjection of cytochrome c. J Biol Chem 272:30299, 1997
34. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627, 1997
35. Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B, Borner C: Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391:496, 1998
36. Zamzami N, Marchetti P, Castedo M, DeCaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G: Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182:367, 1995
37. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssier J-L, Petit PX, Kroemer G: Reduction in mitochondrial potential constitutes an early irreversible step of programmed cell death in vivo. J Exp Med 181:1661, 1995
38. Bossy-Wetzel E, Newmeyer D, Green D: Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarisation. EMBO J 16:37, 1997
39. Hennig B, Kohler H, Neuport W: Transport of cytochrome c into mitochondria: Involvement of specific receptors and of cytochrome c lyase, in Schweyen RJ, Wolf K, Kaudewitz G (eds): Mitochondria. New York, NY, Walter de Gruyter, 1983, p 552
40. Hartl FU, Ostermann B, Guiard B, Neuport W: Successive translocation into and out of the mitochondrial matrix: Targeting of proteins to the intermembrane space by a bipartite signal peptide. Cell 51:1027, 1987
41. Stuart RA, Nicholson DW, Neuport W: Early steps in mitochondrial protein import: Receptor functions can be substituted by the membrane insertion activity of apopcytochrome c. Cell 60:31, 1990
42. Stuart RA, Neuport W: Topogenesis of the inner membrane proteins of mitochondria. Trends Biochem Sci 21:261, 1996
43. Pfanner N, Douglas MG, Endo T, Hoogenraad NJ, Jensen RE, Meijer M, Neuport W, Schatz G, Schmitz UK, Shore GC: Uniform nomenclature for the protein transport machinery of the mitochondrial membranes. Trends Biochem Sci 21:51, 1996
44. Scarpulla RC, Agne KM, Wu R: Isolation and structure of a rat cytochrome gene. J Biol Chem 256:6480, 1986
45. Nicholson DW, Hergersberg C, Neuport W: Role of cytochrome c haem lyase in the import of cytochrome c into mitochondria. J Biol Chem 263:19034, 1988
46. Nye S, Scarpulla RC: In vivo expression and mitochondrial targeting of yeast apoiso-1-cytochrome c fusion proteins. Mol Cell Biol 10:5753, 1990
47. Craig DB, Wallace CJ: Studies of 8-azido ATP adducts reveals two mechanisms by which ATP binding to cytochrome c could inhibit respiration. Biochemistry 34:2686, 1995
48. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC: Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes. Cancer Res 53:4701, 1993
49. de long D, Prins FA, Mason DY, Reed JC, van Omen GB, Kluin PM: Subcellular localisation of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res 54:256, 1994
50. Zoratti M, Szabo I: The mitochondrial permeability transition. Biochim Biophys Acta 1241:139, 1995
51. Muchmore SW, Sattler M, Liang H, Meadows RP, Haran JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong S-L, Ng S-C, Fisk W: X-ray and NMR structure of human Bcl-XL, an inhibitor of programmed cell death. Nature 381:335, 1996
52. Antonsson B, Conti F, Ciavatte A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod J-J, Mazzei G, Maundrell K, Gambalse F, Sadoul R, Martinou J-C: Inhibition of Bax channel-forming ability by Bcl-2. Nature 277:370, 1997
53. Paumen MB, Ishida Y, Han H, Muramatsu M, Eguchi Y, Tsujimoto Y, Honjo T: Direct interaction of the mitochondrial membrane protein carnitine palmitoyltransferase I with bcl-2. Biochem Biophys Res Commun 231:523, 1997
54. Wang HG, Rapp UR, Reed JC: Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629, 1996
55. Peso L, Gonzales-Garcia M, Page C, Herrera R, Nunez G: IL3 induced phosphorylation of BAD through the protein kinase Akt. Science 278:687, 1997
56. Zha J, Harada H, Yang E, Jockel J, Korsmeyer S: Serine phosphorylation of the death antagonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 87:619, 1996
57. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231, 1997
58. Garland JM, Kinnaird A, Elliott K: Cell stimulation by interleukin 3 is a novel process of signal transduction: The rolling cell cycle and its implications for leukaemic transformation. Leukemia 2:476, 1988
59. Ihle JN: Cytokine receptor signalling. Nature 377:591, 1995
60. Due JN: STATs: Signal transducers and activators of transcription. Cell 84:331, 1996
61. Hara T, Miyajima A: Function and signal transduction mediated by the Interleukin 3 receptor system in haematopoiesis. Stem Cells 14:605, 1996
62. Yang Y-C: Human interleukin 3; an overview, in Garland JM, Quesenberry P, Hilton D (eds): Colony Stimulating Factors; Molecular and Cell Biology. New York, NY, Marcel Dekker, 1997, p 227